Password Recovery

Please enter your email address in the field below and will we email your password to you.

Close

LOGIN/REGISTER USING YOUR FACEBOOK ACCOUNT

LOGIN USING YOUR GIG ACCOUNT DETAILS

Lost your password?

NOT A MEMBER? REGISTER!

A LOWTAX NETWORK INTERNATIONAL BUSINESS SMART TOOL
HOME ABOUT ONLINE GIG TOOL JURISDICTION INFORMATION PROVIDERS NEWS ARTICLES & FEATURES

Australian Tax Office Plans TP Probe Of Pharma Sector

Mary Swire, Tax-news.com, Hong Kong

11 September, 2017

Senior officers from the Australian Taxation Office are to undertake a broad review of the transfer pricing practices of Australia-based subsidiaries of pharmaceutical companies.

In a September 7 statement, the ATO said it is "assessing a range of domestic and international tax risks associated with related-party financing, thin capitalization, intellectual property migration, consolidation, business restructures, and research and development."

The ATO said: "Of particular concern to us are non-arm's length conditions operating between entities in connection with their cross-border commercial and financial relations, resulting in the amount brought to tax in Australia not reflecting the contribution made by the Australian operations through functions performed, assets used, and risks assumed. That is, the non-arm's length conditions don't reflect the economic contribution and value creation of Australian activities."

"The pharmaceutical industry is strategically significant to the Australian economy and tax base. Its size, with annual sales of approximately AUD42bn (USD33.8bn), and the diverse nature of companies operating in it, make it an important area of focus for the ATO," it said.

TAGS: compliance | tax | investment | business | tax compliance | tax avoidance | private healthcare | law | intellectual property | audit | Australia | tax authority | multinationals | tax planning | transfer pricing | advance pricing agreement (APA) | tax reform | trade | research and development | Tax |

 

 

SHARE

Share on FacebookTwitter
linkedin share buttonstumbleDeliciousEmail

FOLLOW

FacebookTwitterGoogle+LinkedInTechnorati

Important Notice: Wolters Kluwer TAA Limited has taken reasonable care in sourcing and presenting the information contained on this site, but accepts no responsibility for any financial or other loss or damage that may result from its use. In particular, users of the site are advised to take appropriate professional advice before committing themselves to involvement in offshore jurisdictions, offshore trusts or offshore investments.

All rights reserved. © Wolters Kluwer TAA Limited